Tag

Orion

Outi Vaarala

Orion enters into exclusive agreement with Jemincare

May 27, 2022

Orion Corporation has entered into …

Orion research

FDA accepts Orion’s sNDA and grants Priority Review

May 4, 2022

Orion’s collaboration partner Bayer has …

Liisa Hurme

Liisa Hurme appointed President & CEO of Orion Corporation as of November 2022

April 20, 2022

Orion Corporation’s Board of Directors …

Orion R and D

Orion present results from the CYPIDES trial

February 21, 2022

Clinical phase I data on …

Ahomaki Satu

Orion signs agreement with Marinus Pharmaceuticals

August 4, 2021

Orion Corporation has signed a …

Orion lab Turku

Orion to co-develop CAR T-cell cancer therapy

June 22, 2021

Orion Corporation and the Finnish …

Orion R and D

R&D changes at Orion may lead to personnel reductions

September 14, 2020

The planned changes and renewal …

Outi Vaarala

Orion develops immuno-oncology drug discovery platform

June 11, 2020

Orion is developing an immuno-oncology …

Orion research

Nanoform and Orion collaborate

March 9, 2020

Nanoform and Orion Corporation have …

FDA approved

FDA approves Orion’s and Bayer’s darolutamide

August 1, 2019

The approval of darolutamide is …

Orion production

Orion – one of the most popular employers in Finland

June 19, 2019

In Universum’s student survey on …

reijo- salonen

Orion’s Vice President is CTO of the year

January 30, 2017

Reijo Salonen, Orion’s Senior Vice …

Orion-Espoo

Orion plans for a new market authorisation

December 21, 2016

Orion Corporation has received favorable …

orion

Orion starts strategic collaboration

December 20, 2016

The Wisconsin Technology Innovation Initiative …

Orion Corporation signs license agreement with Janssen Pharmaceuticals

January 15, 2014

Orion Corporation has entered into …

Orion-Espoo

Orion licenses the levosimendan injection rights in the USA and Canada to Phyxius

November 15, 2013

Orion Corporation and Phyxius Pharma …